Author, publication date | Total sample size of patients included in analysis | Proportion of HAI (or incidence rate) | Study timing relative to NPPIs |
---|---|---|---|
Ajayi 2020 | 657 | 4.10% | Before |
Luong-Nguyen 2020 | 301 | 4.90% | Before |
Lakhani 2020 | 288 | 6.48% | Before |
Harada 2020 | 562 | 18.50% | Before |
Borges 2021 | 92 | 22.83% | Before |
Lio 2021 | 28 | 25.00% | Before |
Schwierzeck 2020 | 48 | 27.08% | Before |
Bestillieiro 2020 | 34 | 29.41% | Before |
Romero 2020 | 198 | 33.60% | Before |
Constantino-Shor 2021 | 25 | 40.00% | Before |
Davis 2021 | 222 | 46.29% | Before |
Horing 2020 | 50 | 52.00% | Before |
Caronni 2021 | 11 | 54.50% | Before |
Mazzoleni 2020 | 62 | 65.00% | Before |
Romics 2021 | 179 | 0.00% | During |
Rhee 2020 | 9149 | 0.02% | During |
Ambrosch 2020 | 6106 | 0.16% | During |
Sahoo 2020 | 1769 | 0.28% | During |
Mettias 2020 | 3410 | 0.32% | During |
Demiroz 2020 | 162 | 1.20% | During |
Romao 2020 | 617 | 1.30% | During |
Tabourin 2020 | 68 | 1.50% | During |
Axiotakis 2021 | 501 | 1.80% | During |
Wee 2020 | 45 | 2.20% | During |
Lubansu 2020 | 176 | 2.84% | During |
Jeannon 2021 | 69 | 3.00% | During |
Rajasekaran 2021 | 347 | 4.00% | During |
Yau 2020 | 237 | 4.60% | During |
Meena 2020 | 20 | 5.00% | During |
Sobrado 2020 | 99 | 5.00% | During |
Jewkes 2020 | 133 | 6.00% | During |
Khonyongwa 2020 | 774 | 7.10% | During |
Cheng 2021 | 78 | 15.40% | During |
Thompson 2020 | 160 | 33.00% | During |
Al Lawati 2020 | 28 | 46.43% | During |
Goldberg 2020 | 97 | 53.60% | During |
Long 2021 | 2992 | 0.8–5.0 cases per 10,000 patient days | During |
Biernat 2020 | 39 | 4.87% | Not clear |
Khan 2021 | 173 | 11.00% | Not clear |
Carter 2020 | 1564 | 12.50% | Not clear |
Bhogal 2020 | 179 | 16.00% | Not clear |
Garratti 2020 | 52 | 19.00% | Not clear |
Elkrief 2020 | 252 | 19.00% | Not clear |
Colomer 2020 | 40 | 35.00% | Not clear |
Gaudart 2021 | 100,988 | 155.6 cases (range 19·4–489.5) per 100,000 in-hospital habitants | Not clear |